<?xml version="1.0"?>
<!DOCTYPE SupplementalRecordSet SYSTEM "supp2010.dtd">
<SupplementalRecordSet LanguageCode = "eng">
<SupplementalRecord SCRClass = "2">
  <SupplementalRecordUI>C509829</SupplementalRecordUI>
  <SupplementalRecordName>
   <String>FOLFOXIRI protocol</String>
  </SupplementalRecordName>
  <DateCreated>
   <Year>2006</Year>
   <Month>04</Month>
   <Day>26</Day>
  </DateCreated>
  <ActiveMeSHYearList>
   <Year>2006</Year>
   <Year>2007</Year>
   <Year>2008</Year>
   <Year>2009</Year>
   <Year>2010</Year>
  </ActiveMeSHYearList>
  <Note>FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) protocol for treatment in metastatic colorectal cancer
  </Note>
  <Frequency>2</Frequency>
  <HeadingMappedToList>
   <HeadingMappedTo>
    <DescriptorReferredTo>
     <DescriptorUI>*D000971</DescriptorUI>
     <DescriptorName>
      <String>Antineoplastic Combined Chemotherapy Protocols</String>
     </DescriptorName>
    </DescriptorReferredTo>
   </HeadingMappedTo>
   <HeadingMappedTo>
    <DescriptorReferredTo>
     <DescriptorUI>D002166</DescriptorUI>
     <DescriptorName>
      <String>Camptothecin</String>
     </DescriptorName>
    </DescriptorReferredTo>
    <QualifierReferredTo>
     <QualifierUI>Q000031</QualifierUI>
     <QualifierName>
      <String>analogs &amp; derivatives</String>
     </QualifierName>
    </QualifierReferredTo>
   </HeadingMappedTo>
   <HeadingMappedTo>
    <DescriptorReferredTo>
     <DescriptorUI>D002955</DescriptorUI>
     <DescriptorName>
      <String>Leucovorin</String>
     </DescriptorName>
    </DescriptorReferredTo>
   </HeadingMappedTo>
   <HeadingMappedTo>
    <DescriptorReferredTo>
     <DescriptorUI>D005472</DescriptorUI>
     <DescriptorName>
      <String>Fluorouracil</String>
     </DescriptorName>
    </DescriptorReferredTo>
   </HeadingMappedTo>
   <HeadingMappedTo>
    <DescriptorReferredTo>
     <DescriptorUI>D009944</DescriptorUI>
     <DescriptorName>
      <String>Organoplatinum Compounds</String>
     </DescriptorName>
    </DescriptorReferredTo>
   </HeadingMappedTo>
  </HeadingMappedToList>
  <SourceList>
   <Source>Br J Cancer 2006 Mar 27;94(6):798-805</Source>
  </SourceList>
  <RecordOriginatorsList>
   <RecordOriginator>BMB</RecordOriginator>
   <RecordAuthorizer>BMB</RecordAuthorizer>
  </RecordOriginatorsList>
  <ConceptList>
   <Concept PreferredConceptYN="Y">
    <ConceptUI>M0497446</ConceptUI>
    <ConceptName>
     <String>FOLFOXIRI protocol</String>
    </ConceptName>
    <ConceptUMLSUI>C1702021</ConceptUMLSUI>
    <RegistryNumber>0</RegistryNumber>
    <SemanticTypeList>
     <SemanticType>
      <SemanticTypeUI>T061</SemanticTypeUI>
      <SemanticTypeName>Therapeutic or Preventive Procedure</SemanticTypeName>
     </SemanticType>
    </SemanticTypeList>
    <TermList>
     <Term  ConceptPreferredTermYN="Y"  IsPermutedTermYN="N"  LexicalTag="NON"  PrintFlagYN="Y"  RecordPreferredTermYN="Y">
      <TermUI>T672520</TermUI>
      <String>FOLFOXIRI protocol</String>
      <DateCreated>
       <Year>2006</Year>
       <Month>04</Month>
       <Day>26</Day>
      </DateCreated>
     </Term>
    </TermList>
   </Concept>
  </ConceptList>
 </SupplementalRecord>
</SupplementalRecordSet>
